Form 4: AbbVie Director Melody B. Meyer Reports Stock Transactions
SEC Form 4
Director Melody B. Meyer reports acquisition and disposal of AbbVie common stock and restricted stock units.
Summary
- On May 9, 2025, Melody B. Meyer, a director of AbbVie Inc., reported transactions involving AbbVie's common stock.
- Meyer acquired 1,203 shares of common stock.
- Meyer also disposed of 16,498 shares of common stock.
- These transactions involved restricted stock units awarded under the AbbVie Amended and Restated 2013 Incentive Stock Program.
- These restricted stock units will be paid in shares of AbbVie common stock on a one-to-one basis upon separation from service, death, or a change in control.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing, so the sentiment is neutral.
Future Outlook
The restricted stock units will be paid out in shares of AbbVie common stock upon the director's separation from service, death, or a change in control, as defined in the Program.
Industry Context
This filing is a routine disclosure of stock transactions by a company insider, which is a common practice for publicly traded companies. It provides transparency to investors regarding the actions of company leadership.
Stakeholder Impact
- The filing provides transparency to shareholders regarding insider transactions.
Key Dates
| Date | Description |
|---|---|
| 05/09/2025 | Date of stock acquisition and disposal. |
| 05/13/2025 | Date of signature for the report. |
Keywords
AbbVie, ABBV, Director, Melody B. Meyer, Stock Transaction, Restricted Stock Units, Form 4, SEC Filing
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.